Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites
Clinical trial NCT04051112 · COMPLETED
Trial details
- NCT number
- NCT04051112
- Sponsor
- Sichuan Clover Biopharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-28
- Primary completion
- 2021-12-24
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.